UAB "Swixx Biopharma" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 5,786,464 |
| 138,797 |
| 381,645 |
| 302,989 |
| 7,268 |
| 84.57 |
| 5.24 |
| 905,783 |
| 769,783 |
| 109,242 |
| 1,466,233 |
| 2024 |
|---|
| 5,753,408 |
| 130,908 |
| 325,690 |
| 273,862 |
| 6,231 |
| 83.68 |
| 4.76 |
| 1,179,645 |
| 786,347 |
| 82,301 |
| 1,811,460 |
| 2025 |
|---|
| 5,937,094 |
| 141,024 |
| 483,273 |
| 403,639 |
| 9,588 |
| 84.66 |
| 6.80 |
| 1,583,284 |
| 811,664 |
| 57,037 |
| 2,194,987 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 5,937,094 |
| 141,024 |
| 483,273 |
| 403,639 |
| 9,588 |
| 84.66 |
| 6.80 |
| 1,583,284 |
| 811,664 |
| 57,037 |
| 2,194,987 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
5,937,094 €3 % *
Sales per employee (€)
141,024 €8 % *
Profit before tax (€)
483,273 €48 % *
Net Profit (€)
403,639 €47 % *
Profit per employee (€)
9,588 €54 % *
Total profitability (%)
84.66 %1.17 % *
Net profitability (%)
6.80 %42.86 % *
Equity (€)
1,583,284 €34 % *
Amounts Payable And Liabilities (€)
811,664 €3 % *
Non-current Assets (€)
57,037 €-31 % *
CurrentAssets (€)
2,194,987 €21 % *
